GIOMMONI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.657
NA - Nord America 1.248
AS - Asia 338
OC - Oceania 19
AF - Africa 3
SA - Sud America 1
Totale 3.266
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.242
PL - Polonia 571
RU - Federazione Russa 445
IT - Italia 325
IE - Irlanda 138
HK - Hong Kong 87
SG - Singapore 73
SE - Svezia 61
CN - Cina 59
AT - Austria 37
IN - India 36
JO - Giordania 35
ID - Indonesia 29
AU - Australia 19
CH - Svizzera 19
FI - Finlandia 17
VN - Vietnam 16
DE - Germania 14
GB - Regno Unito 10
CA - Canada 6
NL - Olanda 5
BE - Belgio 3
UA - Ucraina 3
CI - Costa d'Avorio 2
ES - Italia 2
FR - Francia 2
LT - Lituania 2
NO - Norvegia 2
TR - Turchia 2
BR - Brasile 1
DK - Danimarca 1
EG - Egitto 1
KR - Corea 1
Totale 3.266
Salva come PNG Salva come JPEG
Città #
Warsaw 571
Santa Clara 520
Dublin 132
Fairfield 87
Hong Kong 68
Florence 67
Chandler 63
Singapore 59
Ashburn 58
Seattle 44
Woodbridge 37
Vienna 36
Cambridge 34
Wilmington 34
Houston 31
Jakarta 29
Milan 24
Lawrence 22
Altamura 21
Pune 19
Melbourne 18
Shanghai 18
Moscow 17
Bern 16
Dong Ket 16
Mumbai 16
Beijing 15
Princeton 15
Rome 15
Buffalo 13
Boardman 10
Helsinki 10
Boston 9
Ann Arbor 8
West Jordan 8
Medford 7
Bremen 6
Brescia 6
Dearborn 6
New York 6
San Diego 6
Los Angeles 5
Toronto 5
Amandola 4
Cinisello Balsamo 4
Falls Church 4
Hillsboro 4
Naples 4
Phoenix 4
Yubileyny 4
Alba 3
Brussels 3
Cagliari 3
Genoa 3
Hangzhou 3
Kent 3
London 3
Munich 3
Mykolayiv 3
San Marco Evangelista 3
Shenzhen 3
Siena 3
Washington 3
Abidjan 2
Ancona 2
Arezzo 2
Argelato 2
Barcelona 2
Brusaporto 2
Carmignano 2
Catania 2
Cernusco sul Naviglio 2
Forlì 2
Formia 2
Gaggiano 2
Istanbul 2
Jacksonville 2
Jinan 2
Lappeenranta 2
Lecce 2
Mileto 2
Monfalcone 2
Newark 2
Novoli 2
Orta Nova 2
Oslo 2
Padova 2
Palermo 2
Paris 2
Parma 2
Perugia 2
Pietrasanta 2
Prescot 2
Reggio Emilia 2
San Giovanni Valdarno 2
Taranto 2
Treviso 2
Turin 2
Udine 2
Varese 2
Totale 2.348
Salva come PNG Salva come JPEG
Nome #
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: A phase II study 277
hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications 263
VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort. 252
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification 206
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 147
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 136
Update on gastric cancer treatments and gene therapies 135
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 133
Regorafenib also can cause osteonecrosis of the jaw 109
hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study. 108
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 99
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 98
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 96
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 95
Results of the observational prospective RealFLOT study 86
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 86
Editorial: Redox Potential and Metabolic Behavior in Gastrointestinal Cancers 82
Somatostatin analogs in pregnant patients with neuroendocrine tumor 81
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 81
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study) 73
Systemic Sclerosis Association with Malignancy 72
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 70
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research 70
Immune-related adverse events in oncological patients treated with immune checkpoint inhibitors 69
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 67
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 66
Treatment Strategy for Oligometastatic Gastric Cancer: Brief Considerations 61
Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine 53
Response 45
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 44
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 43
Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients 16
null 3
Totale 3.322
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020168 0 0 0 0 0 0 30 37 26 20 51 4
2020/2021283 24 30 3 42 18 27 18 19 30 46 7 19
2021/2022114 2 2 5 3 4 1 4 17 11 8 26 31
2022/2023490 23 70 17 24 36 97 67 40 61 14 19 22
2023/2024448 8 29 33 17 30 75 27 80 11 42 46 50
2024/20251.333 49 164 106 280 472 262 0 0 0 0 0 0
Totale 3.322